Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;50(5):1953-1978.
doi: 10.1007/s00261-024-04636-7. Epub 2024 Nov 11.

Imaging of cystic fibrosis manifestations in the abdomen

Affiliations
Review

Imaging of cystic fibrosis manifestations in the abdomen

Shane Dunnion et al. Abdom Radiol (NY). 2025 May.

Abstract

Cystic fibrosis is a common inherited autosomal recessive disease affecting 35,000 persons in the United States. It is caused by mutations of the cystic fibrosis transmembrane regulator (CFTR) gene, located on the long arm of chromosome 7.This protein carries chlorine in the membranes of epithelial cells of exocrine glands. Mutations in the CFTR gene results in production of abnormally viscous mucus. Although it primarily affects the lungs, cystic fibrosis is a multisystem disease with involvement of extra thoracic organs including the liver, pancreas, kidneys and digestive tract.With advances in the management of cystic fibrosis resulting in improved life expectancy, cystic fibrosis patients are surviving into adulthood and extrapulmonary disease has become more commonplace. It is essential that radiologists are aware of the spectrum of potential manifestations of cystic fibrosis to allow accurate diagnosis.The purpose of this manuscript is to provide an overview of the pathophysiology and imaging findings of abdominal entities unique to patients with cystic fibrosis. We will present a wide spectrum of renal, pancreatic, gastrointestinal, hepatobiliary and post-transplant cases describing the typical findings that will assist radiologists in providing a timely diagnosis for patients with cystic fibrosis.

Keywords: Abdomen; Cystic fibrosis; Gastrointestinal; Pancreatic transplant; Renal.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL and Bush A (2015). Cystic fibrosis. Nat Rev Dis Primers 2015; 1: 15010. https://doi.org/10.1038/nrdp.2015.10 . - DOI
    1. Pollock R (2005). The treatment of cystic fibrosis in Ireland: problems and solutions. The Cystic Fibrosis Association of Ireland, 1:1–30.
    1. Hartmut G and Ratjen F (2023). Cystic fibrosis, N Engl J Med, 389:1693-707. https://doi.org/10.1056/nejmra2216474 - DOI
    1. Davis PB (2011). Therapy for cystic fibrosis: the end of the beginning? N Engl J Med, 365(18):1734–1735. https://doi.org/10.1056/NEJMe1110323 - PubMed - DOI
    1. Ramsey B, Bonnie W et al (2011). A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation. N Engl J Med, 365(18):1663–72. https://doi.org/10.1056/NEJMoa1105185 . - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources